Skip to content

A Study on the Specific Efficacy and Target Brain Regions of the 'Sinew-Substituting-Bone' Acupoint Therapy for Patients with KOA Chronic Pain and Pain-Related Emotional Disorders

A Study on the Specific Efficacy and Target Brain Regions of the 'Sinew-Substituting-Bone' Acupoint Therapy for Patients with KOA Chronic Pain and Pain-Related Emotional Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000389
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-03-31
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Acupoint Group:Basic treatment plan plus "acupoint therapy using tendons instead of bones"
Sham Acupoint Group:Basic treatment plan + Sham acupoint therapy
Health Group:Basic treatment plan plus "acupoint therapy using tendons instead of bones"

Sponsors

Beijing University of Chinese Medicine Dongzhimen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: KOA Subjects: (1) Meet the diagnostic criteria of the Orthopedics Branch of the Chinese Medical Association's "Guidelines for the Diagnosis and Treatment of Bone Joints" (2007 edition) and the American College of Rheumatology diagnostic standards; (2) Age 40-75 years, gender; (3) KL grade 2 or 3; (4) KOA history of 6 months or more; (5) Pain VAS total score of 3-7 points; (6) Mild to moderate anxiety and/or mild to moderate depression (SAS, SDS scores of 50-69 points); (7) If the patient has KOA in both legs, select the more severe one for the study; (8) The subject themselves is informed and consents, and voluntarily signs the informed consent form. Healthy Subjects: (1) Age 40-75 years; gender; (2) No other chronic diseases that affect pain perception or emotional status; (3) No severe underlying diseases; (4) No history of severe mental illness or cognitive dysfunction; (5) The subject themselves is informed and consents, and voluntarily signs the informed consent form.

Exclusion criteria

Exclusion criteria: KOA Subjects: (1) Secondary arthritis or joint replacement surgery; (2) Skin diseases at the treatment site; (3) Severe primary diseases or severe mental illness (e.g., severe depression); (4) Other pain-related diseases; (5) Unable to cooperate with examinations or other contraindications for magnetic resonance imaging (Magnetic Resonance Imaging, MRI); (6) History of arthroscopy, knee joint injections, acupuncture, or massage therapy within the past 6-12 months; (7) Participation in other clinical trials; (8) Oral administration of hormonal medications; (9) Females during menstruation, pregnancy, lactation, or with pregnancy plans. Healthy Subjects: (1) History of knee joint diseases or lower limb pain; (2) Recent history of other surgeries; (3) Recent use of hormonal medications or other drugs affecting joint health; (4) Females during pregnancy, lactation, or with pregnancy plans.

Design outcomes

Primary

MeasureTime frame
visual analogue scale;

Secondary

MeasureTime frame
The Western Ontario and McMaster Universities Arthritis Index;self-rating anxiety scale;self-rating depression scale;the 12-items short form health survey;

Countries

China

Contacts

Public ContactWang Xiyou

Beijing University of Chinese Medicine Dongzhimen Hospital

dzmyywxy@163.com13810111889

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026